This would aid the volume of plasma collected per center, but also reduce blood donor screening. We also think CSL benefits from superior fractionation expertise and quality processes, enabling ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.

Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...

CSL) reported a rise in half-year net profit, driven primarily by robust performance in its blood plasma division. The company's CSL Behring unit, which focuses on plasma-derived therapies ...

Learn More If you have been thinking about buying CSL Ltd (ASX: CSL) shares, then read on. That's because Goldman Sachs has just named another reason to buy the biotechnology giant's shares.

Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, Asia and the Middle East, Africa ...

ALBANY, N.Y. (NEWS10) — Cookie booths popped up around the Capital Region on Friday, as the Girl Scouts of Northeastern New York (GSNENY) kick off their booth sale season. Troops will be ...

Plasma collections & margin recovery in focus By contrast, CSL’s plasma arm – CSL Behring – emerged as key to current support for the company and its outlook. Immunoglobulin sales remain strong, with ...

Nearly 700,000 women are to be recruited to take part in an NHS artificial intelligence (AI) breast cancer screening trial across the UK. Five different AI platforms will be tested across 30 sites ...